FdaApplication
NDA 021355
Identifiers
- fda_app_no: NDA021355
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER HEALTHCARE PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2005-09-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANGELIQ | DROSPIRENONE; ESTRADIOL | 0.5MG;1MG | TABLET;ORAL |
| ANGELIQ | DROSPIRENONE; ESTRADIOL | 0.25MG;0.5MG | TABLET;ORAL |
2 products